181 related articles for article (PubMed ID: 11443182)
21. Changes in the serum growth factors and osteoprotegerin after bone marrow transplantation: impact on bone and mineral metabolism.
Baek KH; Lee WY; Oh KW; Kim HS; Han JH; Kang MI; Cha BY; Lee KW; Son HY; Kang SK; Kim CC
J Clin Endocrinol Metab; 2004 Mar; 89(3):1246-54. PubMed ID: 15001618
[TBL] [Abstract][Full Text] [Related]
22. Skeletal changes in osteoprotegerin and receptor activator of nuclear factor-kappab ligand mRNA levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Rettmer E; Eriksen EF; Hegedüs L; Beck-Nielsen H; Abrahamsen B
Bone; 2004 Jul; 35(1):256-65. PubMed ID: 15207766
[TBL] [Abstract][Full Text] [Related]
23. Circulating osteoprotegerin and receptor activator of NF-kappaB ligand system are associated with bone metabolism in middle-aged males.
Oh KW; Rhee EJ; Lee WY; Kim SW; Baek KH; Kang MI; Yun EJ; Park CY; Ihm SH; Choi MG; Yoo HJ; Park SW
Clin Endocrinol (Oxf); 2005 Jan; 62(1):92-8. PubMed ID: 15638876
[TBL] [Abstract][Full Text] [Related]
24. Serum osteoprotegerin and its relationship with bone mineral density and markers of bone turnover.
Indridason OS; Franzson L; Sigurdsson G
Osteoporos Int; 2005 Apr; 16(4):417-23. PubMed ID: 15776220
[TBL] [Abstract][Full Text] [Related]
25. Bioavailable estradiol may be an important determinant of osteoporosis in men: the MINOS study.
Szulc P; Munoz F; Claustrat B; Garnero P; Marchand F; Duboeuf F; Delmas PD
J Clin Endocrinol Metab; 2001 Jan; 86(1):192-9. PubMed ID: 11232000
[TBL] [Abstract][Full Text] [Related]
26. Circulating osteoprotegerin and leptin levels in postmenopausal women with and without osteoporosis.
Grigorie D; Neacşu E; Marinescu M; Popa O
Rom J Intern Med; 2003; 41(4):409-15. PubMed ID: 15526523
[TBL] [Abstract][Full Text] [Related]
27. Serum osteoprotegerin as a determinant of bone metabolism in a longitudinal study of human pregnancy and lactation.
Naylor KE; Rogers A; Fraser RB; Hall V; Eastell R; Blumsohn A
J Clin Endocrinol Metab; 2003 Nov; 88(11):5361-5. PubMed ID: 14602774
[TBL] [Abstract][Full Text] [Related]
28. Osteoprotegerin levels in primary hyperparathyroidism: effect of parathyroidectomy and association with bone metabolism.
Stilgren LS; Hegedüs LM; Beck-Nielsen H; Abrahamsen B
Calcif Tissue Int; 2003 Sep; 73(3):210-6. PubMed ID: 14667132
[TBL] [Abstract][Full Text] [Related]
29. The relationship between circulating osteoprotegerin levels and bone mineral metabolism in healthy women.
Oh KW; Rhee EJ; Lee WY; Kim SW; Oh ES; Baek KH; Kang MI; Choi MG; Yoo HJ; Park SW
Clin Endocrinol (Oxf); 2004 Aug; 61(2):244-9. PubMed ID: 15272921
[TBL] [Abstract][Full Text] [Related]
30. Osteoprotegerin and bone mass in squamous cell head and neck cancer patients.
Valero C; Olmos JM; Rivera F; Hernández JL; Vega ME; Macías JG
Calcif Tissue Int; 2006 Jun; 78(6):343-7. PubMed ID: 16830204
[TBL] [Abstract][Full Text] [Related]
31. Serum osteoprotegerin and sex steroid levels in patients with prostate cancer.
Varsavsky M; Reyes-Garcia R; Avilés Perez MD; Gonzalez Ramírez AR; Mijan JL; Muñoz-Torres M
J Androl; 2012; 33(4):594-600. PubMed ID: 21903971
[TBL] [Abstract][Full Text] [Related]
32. Circulating osteoprotegerin in women during GnRH-agonist treatment and their relationships with mineral components and biomarkers of bone turnover.
Uemura H; Yasui T; Umino Y; Niki H; Takikawa M; Saito S; Furumoto H; Irahara M
Bone; 2003 Nov; 33(5):860-6. PubMed ID: 14623063
[TBL] [Abstract][Full Text] [Related]
33. Cortical bone status is associated with serum osteoprotegerin concentration in men: the STRAMBO study.
Szulc P; Hawa G; Boutroy S; Vilayphiou N; Schoppet M; Chapurlat R; Hofbauer LC
J Clin Endocrinol Metab; 2011 Jul; 96(7):2216-26. PubMed ID: 21565793
[TBL] [Abstract][Full Text] [Related]
34. Osteoclastic function is accelerated in male patients with type 2 diabetes mellitus: the preventive role of osteoclastogenesis inhibitory factor/osteoprotegerin (OCIF/OPG) on the decrease of bone mineral density.
Suzuki K; Kurose T; Takizawa M; Maruyama M; Ushikawa K; Kikuyama M; Sugimoto C; Seino Y; Nagamatsu S; Ishida H
Diabetes Res Clin Pract; 2005 May; 68(2):117-25. PubMed ID: 15860239
[TBL] [Abstract][Full Text] [Related]
35. Changes in the serum sex steroids, IL-7 and RANKL-OPG system after bone marrow transplantation: influences on bone and mineral metabolism.
Baek KH; Oh KW; Lee WY; Tae HJ; Rhee EJ; Han JH; Cha BY; Kim YJ; Lee KW; Son HY; Kang SK; Kim CC; Kang MI
Bone; 2006 Dec; 39(6):1352-60. PubMed ID: 16905375
[TBL] [Abstract][Full Text] [Related]
36. Serum osteoprotegerin and renal osteodystrophy.
Coen G; Ballanti P; Balducci A; Calabria S; Fischer MS; Jankovic L; Manni M; Morosetti M; Moscaritolo E; Sardella D; Bonucci E
Nephrol Dial Transplant; 2002 Feb; 17(2):233-8. PubMed ID: 11812872
[TBL] [Abstract][Full Text] [Related]
37. Changes in osteoprotegerin/RANKL system, bone mineral density, and bone biochemicals markers in patients with recent spinal cord injury.
Maïmoun L; Couret I; Mariano-Goulart D; Dupuy AM; Micallef JP; Peruchon E; Ohanna F; Cristol JP; Rossi M; Leroux JL
Calcif Tissue Int; 2005 Jun; 76(6):404-11. PubMed ID: 15812577
[TBL] [Abstract][Full Text] [Related]
38. Cystatin C as a potential predictor of osteoprotegerin levels in healthy men, a cross-sectional, observational study.
Kulcsar-Jakab E; Petho Z; Pap Z; Kalina E; Foldesi R; Balogh A; Antal-Szalmas P; Bhattoa HP
BMC Musculoskelet Disord; 2015 Aug; 16():227. PubMed ID: 26311162
[TBL] [Abstract][Full Text] [Related]
39. Osteoprotegerin and bone turnover markers in heavily pretreated HIV-infected patients.
Seminari E; Castagna A; Soldarini A; Galli L; Fusetti G; Dorigatti F; Hasson H; Danise A; Guffanti M; Lazzarin A; Rubinacci A
HIV Med; 2005 May; 6(3):145-50. PubMed ID: 15876279
[TBL] [Abstract][Full Text] [Related]
40. Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen.
Khosla S; Melton LJ; Atkinson EJ; O'Fallon WM; Klee GG; Riggs BL
J Clin Endocrinol Metab; 1998 Jul; 83(7):2266-74. PubMed ID: 9661593
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
